Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 218,300 | 475,900 | 287,400 | 269,200 | 811,500 |
Receivables | 385,800 | 743,700 | 887,100 | 1,078,900 | 431,100 |
Inventories | 1,551,500 | 1,949,300 | 1,973,800 | 2,171,400 | 1,523,100 |
Other current assets | 278,800 | 452,800 | 1,197,700 | 457,300 | 1,577,300 |
TOTAL | $2,434,400 | $3,621,700 | $4,346,000 | $3,976,800 | $4,343,000 |
Non-Current Assets | |||||
PPE Net | 729,700 | 1,240,200 | 1,253,000 | 1,437,200 | 668,200 |
Investments And Advances | 42,200 | 0 | 0 | 0 | 51,900 |
Intangibles | 4,202,900 | 6,521,100 | 6,787,000 | 6,793,000 | 4,364,300 |
Other Non-Current Assets | 82,600 | 192,200 | 512,600 | 316,000 | 3,246,600 |
TOTAL | $5,057,400 | $7,953,500 | $8,552,600 | $8,546,200 | $8,331,000 |
Total Assets | $7,491,800 | $11,575,200 | $12,898,600 | $12,523,000 | $12,674,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | 553,400 | 280,000 | N/A |
Accounts payable and accrued liabilities | 206,100 | 399,500 | 426,200 | 486,800 | 189,300 |
Other current liabilities | 524,200 | 827,000 | 721,400 | 851,700 | 521,000 |
TOTAL | $758,700 | $1,646,000 | $2,004,800 | $1,675,900 | $2,106,900 |
Non-Current Liabilities | |||||
Long Term Debt | 1,902,100 | 2,320,600 | 3,290,100 | 3,671,300 | 3,620,600 |
Other Non-Current Liabilities | 356,200 | 644,300 | 613,400 | 596,600 | 863,301 |
TOTAL | $2,633,400 | $3,610,700 | $4,615,600 | $4,944,500 | $4,879,101 |
Total Liabilities | $3,392,100 | $5,256,700 | $6,620,400 | $6,620,400 | $6,986,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 156,721 | 155,459 | 154,469 | 154,164 | 153,422 |
Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
Retained earnings | 5,892,600 | 8,202,200 | 7,849,300 | 7,550,400 | 7,499,300 |
Other shareholders' equity | -299,300 | -350,200 | 18,800 | -28,600 | -150,500 |
TOTAL | $4,099,700 | $6,318,500 | $6,278,200 | $5,902,600 | $5,688,000 |
Total Liabilities And Equity | $7,491,800 | $11,575,200 | $12,898,600 | $12,523,000 | $12,674,000 |